Showing posts with label GlaxoSmithKline. Show all posts
Showing posts with label GlaxoSmithKline. Show all posts

Friday, 26 July 2013

June 2013: Following Woodford update.

So, each of "the 3 ways to follow Woodford" pulled back from what are now month end closing all time highs for this experiment strategy
Still out in front with a gain of 20.08% is a direct investment in the Woodford managed Invesco Perpetual flagship fund, the High Income Fund.
Close behind on 17.62% is still the alternative Woodford managed Edinburgh Investment Trust.
And, still lagging in third place is the 3 picks option with a gain of 15.13%.

But, healthy gains are now being seen across all 3 options.

Looking at the 3 picks, all 3 individual companies continue to be top 10 holdings for the High Income Fund so no changes are required (http://www.invescoperpetual.co.uk: Invesco Perpetual High Income Fund).

Shares Price Value & Gain
Inv. Perp. High Income 1110.14 6.49 7204.84 20.08%
Residue 0.00
Dividends
Total 6000 7204.84 20.08%
Edinburgh Investment Trust 1182.00 5.65 6678.30 11.31%
Residue 0.43
Dividends 378.24
Total 6000 7056.97 17.62%
3 Picks
BAT 61.00 33.67 2053.87 2.69%
Glaxo 138.00 16.48 2274.24 13.71%



BT 788.00 3.09 2434.92 11.05%
Residue 0.00
Dividends 144.51
Total 6000 6907.54 15.13%
Transactions in the month:
Invesco Perp. High Income N/A
Edinburgh Inv. Trust
3 Picks


Click to enlarge, close to return.

Interesting to see the chart which illustrates the battling roller coaster ride with each of the choices taking their turn out in front.
But since the turn of the year both of the Woodford managed options opened a significant gap over the 3 picks which has only just started to close.
As far as I can surmise this came from 2 distinct elements, the first being a surge in the share price and fortunes of Rolls-Royce contributing to the Fund and Trust but not the 3 picks.
Secondly, and at the same time, the pullback and subsequent sale of Vodafone from Woodford's managed funds had a disproportionately negative impact on the 3 picks as it was originally a 33% holding.
This also forced my hand, creating a negative timing issue, with a sale and purchase of BT which unfortunately had already given gains to the funds but forcing me to buy within touching distance of recent highs meant that no such gain was contributed to the 3 picks option.



Related post links:

Sunday, 2 June 2013

May 2013: Following Woodford update

Hmm, well the 3 picks continues to make a charge and has now recorded a 17.39% increase since the beginning of the experiment. 
Still not enough to take it off the bottom spot as the Edinburgh Investment Trust is still showing a 20.57% increase.
But, the flagship High Income Fund managed by Neil Woodford remains out in front with a 23.07% increase.

Dividends came into the Investment Trust and the 3 picks, the latter receiving its dividend directly from British American Tobacco.
All 3 elements of the "picks" have stepped up lately with BT in particular being boosted by reception of its new marketing plans involving free issue of its quota of Premier League games with Broadband packages.
But it has also been a long time since Glaxo was last at £17, and BAT is continuing its long term rising trend.

As at the end of April, the 3 picks occupied 19.56% of the High Income Fund and maintained a position within the Funds top 10 holdings (http://www.invescoperpetual.co.uk: Invesco Perpetual High Income Fund).


Shares 31.05.13
Inv. Perp. High Income 1110.14 6.65 7384.13 23.07%
Residue 0.00
Dividends
Total 6000 7384.13 23.07%
Edinburgh Investment Trust 1182.00 5.85 6914.70 15.25%
Residue 0.43
Dividends 319.14
Total 6000 7234.27 20.57%
3 Picks
BAT 61.00 36.23 2210.03 10.50%
Glaxo 138.00 17.14 2364.63 18.23%







BT 788.00 3.02 2380.55 8.57%
Residue 0.00
Dividends 87.96
Total 6000 7043.17 17.39%
Transactions in the month:
Invesco Perp. High Income N/A
Edinburgh Inv. Trust
Edinburgh Inv. Trust 23/05/2013 Div 59.1
3 Picks
BAT 08/05/2013 Div 56.55




Click to enlarge, close to return.



Related post links:


Note: Unlike my Portfolio updates (Portfolio Updates.) which reflects an actual investment portfolio, "following" Woodford is an experimental strategy and a virtual portfolio.

Wednesday, 22 May 2013

April 2013; "following Woodford" update.

April's update of the "following Woodford" experiment and all 3 options are continuing to push ahead with the 3 picks actually managing to close a little of what has been an expanding gap between the 2 fund options directly manage by Neil Woodford and the 3 picks option.

Both of the actually managed funds are now punching up 20% gains with the 3 picks now notching up 11.24% incl. the receipt of a dividend courtesy of GlaxoSmithKline.



Shares  Price £Value  %Growth 
Inv. Perp. High Income 1110.14 6.50 7214.94 20.25%
Residue 0.00
Dividends
Total 6000 7214.94 20.25%
Edinburgh Investment Trust 1182.00 5.90 6967.89 16.13%
Residue 0.43
Dividends 260.04
Total 6000 7228.36 20.47%
3 Picks
BAT 61.00 35.66 2175.26 8.76%
Glaxo 138.00 16.61 2291.49 14.57%
Vodafone 1191.00 0.00
BT 788.00 2.76 2176.46 -0.74%
Residue 0.00
Dividends 31.41
Total 6000 6674.62 11.24%
Transactions in the month:
Invesco Perp. High Income N/A
Edinburgh Inv. Trust
3 Picks
Glaxo 11/04/2013 Div 30.36



Click to enlarge, close to return.

Related post links:

Wednesday, 2 January 2013

December 2012: "following Woodford" update.

Well the 3 ways to follow Woodford experiment is starting to look a little sickly for the 3 picks choice which continues to lag the 2 Woodford managed options which have changed position again following a dividend being received into the Edinburgh Investment Trust which was enough to push its nose out in front with a total gain of 4.02%.
The High Income Fund is still running close though with a gain of 3.34%.
Unfortunately the "positive" news stops there though, as the 3 picks option is now showing a -4.35% loss to date.


Shares Price  £Value  %Gain
Inv. Perp. High Income 1110.14 5.59 6200.60 3.34%
Residue 0.00
Dividends
Total
6000 6200.60 3.34%
Edinburgh Investment Trust 1182.00 5.11 6040.02 0.67%
Residue 0.43
Dividends 200.94

Total 6000 6241.39 4.02%
3 Picks
BAT 61.00 31.21 1903.81 -4.81%
Glaxo 138.00 13.35 1842.30 -7.89%
Vodafone 1191.00 1.54 1839.50 -8.03%
Residue 3.68
Dividends 149.72
Total 6000 5739.01 -4.35%




Click to enlarge, close to return.

Even though the 3 picks are a virtual portfolio (I do hold Vodafone), it is still disappointing to see the almost straight line deterioration since its peak in July at a level that has yet to be breached by any of the options.
Strange to suggest but looking at the chart and the individual performances since that July peak, the 3 picks are now looking like a contrarian option to both the Invesco Perpetual High Income Fund and the Edinburgh Investment Trust.
Which, given the original premise, and the fact that the 3 picks were taken from within the 3 largest weighted sectors in the High Income Fund's top 10, seems very strange indeed.

With the exception of Vodafone, where Neil Woodford appears to have reduced his stake, the global pressures on Pharmaceuticals (patent cliffs etc), and Tobacco (plain packaging, political will etc), should be felt at least proportionately by the Fund and Trust given their greater exposure to those sectors.
Which just leaves individual company performance as the possible defining factor whether that be another company from within the same sector exposure e.g Astrazeneca outperforming Glaxo, or a company from outside the top 10 which would have to go some given its lower weighted position.

Fair to say that the current disparity in performance is the exact opposite of what I was expecting, given management charges, and whilst I have reasonable confidence that future dividends will soon see the 3 picks turn positive, it does look like they will have some way to go to catch/overhaul the 2 Woodford managed options.
Particularly given that any out-performance in the 3 picks will also contribute to the 2 managed options.

The unexpected turnaround and apparent contrarian position does make the trial very interesting though.


Related article links:

Earlier related posts:
- November 2012: "following Woodford" update

Thursday, 8 November 2012

October 2012: "following Woodford" update.

Wow, the last couple of months have proven a torrid for this trial strategy as the market casts doubts over the growth prospects of "defensive's".
This has seen the constituents of the 3 picks pull back from year highs causing the mini portfolio to slump against its 2 alternatives.

Not altogether surprising given that the 3 picks was given the biggest handicap to begin with, these being:
- the greatest costs to set up with, from both dealing and stamp duty (New Trial Investment Strategy: 3 ways to follow Neil Woodford!). In contrast the HIF had zero set up costs as could be the case from a fund supermarket.
- 2 of the 3 picks were trading ex.dividend at inception. In contrast due to lead time between ex dividend and payment these 2 dividends would subsequently benefit the other 2 options.
- more concentrated/low diversification with just 3 picks from 3 sectors.
- as well as the dealing charges, the 3 picks also started life with the highest amount of uninvested "residue" funds, £3.68 (£2000 tranches and you can only buy whole shares), which also means it started life with the lowest actual investment amount.
- lastly, the 3 picks are also building up an uninvested amount of cash from dividends whereas this is more immediately re-invested into the HIF and its accumulation units.

Despite these handicaps the 3 picks did rise to the top of the pile during August and September before falling foul of recent volatility which possibly highlights the risk of low diversification.

But the fact is that the table has been turned on its head with the Invesco Perpetual High Income Fund seeming to defy gravity at present despite including large weightings in the 3 picks (their selection being derived from the fund's top 10 holdings at the time New proposed investment strategy based upon Neil Woodford's top 10.).

As feared last month though, Vodafone's slump has seen it fall outside of the HIF's top 10 but I think that I will retain it for the 12 months though (effectively setting a guideline for holding against short term volatility). 
The alternative being to trade it for BT as my original premise was to pick one from each of the 3 most represented sectors in the HIF's top 10, and Telecom's continue to be 1 of the 3.

So 2 of the 3 ways remain in positive territory (and both managed by Neil Woodford).
Which just leaves the 3 picks as the only one in negative territory then, by £64.93, or 1.08%, which is also roughly equal to the estimated £67.15 that was used to cover the set-up cost of the portfolio. 
So really it is still up on its -1.2% starting point! (New Trial Investment Strategy: 3 ways to follow Neil Woodford!).

Qty £price£value %gain 
Inv. Perp. High Income 1110.14 5.53 6143.87 2.40%
Residue 0.00
Dividends
Total 6000 6143.87 2.40%

Edinburgh Investment Trust

1182.00

4.99

5898.18

-1.70%
Residue 0.43
Dividends 167.58
Total 6000 6066.19 1.10%
3 Picks
BAT 61.00 30.70 1872.70 -6.37%
Glaxo 138.00 13.87 1914.06 -4.30%
Vodafone 1191.00 1.70 2020.65 1.03%
Residue 3.68
Dividends 123.98
Total 6000 5935.07 -1.08%
Transactions in the month:
Invesco Perp. High Income N/A
Edinburgh Inv. Trust N/A
3 Picks
Glaxo 04/10/2012 Div 23.46



The only transaction in the month was a £23.46 dividend received by the 3 picks from Glaxo.
And the chart, which is starting to look like a roller coaster (a loop the loop would be interesting!), is as follows:

Click to enlarge, close to return.


Looking at the chart, it is Interesting to see that the performance of each of the 3 options was very closely aligned for the first 2 months before embarking on more volatile journeys.
Will they come back together again or continue to swing wildly around each other, only time will tell.

But it has been an interesting first 7 months for the "3 ways" to follow Woodford trial and a new guideline is in place ie. to hold a share for the 12 months despite it dropping out of the HIF's top 10. 
This is still a developing trial though, which includes the guidelines. And, at this stage, 2 further complications to the new guideline haven't been crossed yet, which are:
- slipping out the top 10 results in the selected industry sector no longer being one of the top 3 weightings in the to 10.
- the share being sold by out of the HIF which might seem an extreme scenario but one that Neil Woodford appears to have enacted on a number of occasions exiting banks, BP, regulated utilities, and most recently, Tesco.

What I do also need to give some thought to though, is the question of timing and dividend re-investment, which could affect both the Edinburgh Investment Trust, and the 3 picks options. The 3rd option, HIF accumulation units automatically re-invest dividends.
My thoughts were to allow them to build up before re-investment but what is a suitable level and, in the case of the 3 picks (I need a better title!), what to re-invest back into, the options being,
- equally into the 3 companies,
- split in the same way as the dividends were issued, ie back into the issuing share
- into just one of the shares, worst/middle/best performing
or if allowed to build up sufficiently (that could take 5/6 years), add a 4th holding at £2000.

If left to drag on without a plan, this might give a further advantage to the HIF option which will always be fully invested.
A bit of thought required then.

Related article links:

Earlier related posts:


Note: Unlike my Portfolio updates (Portfolio Updates.) which reflects an actual investment portfolio, following Woodford is an experimental strategy and a virtual portfolio.
However, I do hold an investment in Vodafone.